Advances in the Interactions between Nanoparticles and Cells

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Biophysics".

Deadline for manuscript submissions: closed (25 June 2023) | Viewed by 2999

Special Issue Editor


E-Mail Website
Guest Editor
Fujian Key Laboratory of Oral Disease, School and Hospital of Stomatology, Fujian Medical University, 88 Jiaotong Rd, Fuzhou 350004, China
Interests: oral biology; nanomaterials; gene regulation; cancer biology

Special Issue Information

Dear Colleagues,

Rapid progress in nanotechnology in recent decades has enabled the development of multiple exciting materials for biomedical applications. Nanoparticles, with dimensions ranging from 1 to 100 nm, include exosomes derived from plant and animal cells and different types of engineered or synthetic nanomaterials such as inorganic elements, polymers, lipids, hydrogels, carbon nanoparticles, and quantum dots. The small size and large surface area account for the extensive use of nanoparticles in various areas such as cosmetics, electronics, and both diagnostic and therapeutic medical applications. The physicochemical properties of nanoparticles (such as size, surface charge, and shape) affect their function and uptake by cells, the mechanisms of which are not fully understood. The uptake of the same nanoparticles also varies from cell to cell. It is crucial to investigate the mechanisms of action or the influencing elements in order to create highly bioavailable nanoparticles that are better suited for target cell uptake. The interaction of these nanoparticles with cells also holds countless opportunities for the diagnosis and treatment of diseases. Therefore, in this Special Issue, we invite you to improve the current knowledge of any aspect of nanoparticle–cell interactions, discussing the function of novel nanomaterials, the cytotoxicity and biosafety of nanoparticles, specific mechanisms and influencing factors of nanoparticle–cell interactions, possible mechanisms of nanoparticle involvement in disease development, and the application of nanoparticles as disease diagnostic and therapeutic tools in preclinical models.

Prof. Dr. Dali Zheng
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanoparticels
  • cellular interaction
  • nanotechnology
  • drug delivery
  • biosafety

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

26 pages, 4647 KiB  
Review
Biogenic Silver Nanoparticles for Targeted Cancer Therapy and Enhancing Photodynamic Therapy
by Glory Kah, Rahul Chandran and Heidi Abrahamse
Cells 2023, 12(15), 2012; https://doi.org/10.3390/cells12152012 - 07 Aug 2023
Cited by 1 | Viewed by 1941
Abstract
Different conventional therapeutic procedures are utilized globally to manage cancer cases, yet the mortality rate in patients with cancer remains considerably high. Developments in the field of nanotechnology have included novel therapeutic strategies to deal with cancer. Biogenic (green) metallic silver nanoparticles (AgNPs) [...] Read more.
Different conventional therapeutic procedures are utilized globally to manage cancer cases, yet the mortality rate in patients with cancer remains considerably high. Developments in the field of nanotechnology have included novel therapeutic strategies to deal with cancer. Biogenic (green) metallic silver nanoparticles (AgNPs) obtained using plant-mediated protocols are attractive to researchers exploring cancer treatment. Biogenic AgNPs present advantages, since they are cost-effective, easy to obtain, energy efficient, and less toxic compared to chemically and physically obtained AgNPs. Also, they present excellent anticancer abilities thanks to their unique sizes, shapes, and optical properties. This review provides recent advancements in exploring biogenic AgNPs as a drug or agent for cancer treatment. Thus, great attention was paid to the anticancer efficacy of biogenic AgNPs, their anticancer mechanisms, their efficacy in cancer photodynamic therapy (PDT), their efficacy in targeted cancer therapy, and their toxicity. Full article
(This article belongs to the Special Issue Advances in the Interactions between Nanoparticles and Cells)
Show Figures

Figure 1

Back to TopTop